Novo Medi Sciences Private Limited, a active private limited company, was established on 29 June 2013 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U33110MH2013PTC245027. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹19.70 Cr and a paid-up capital of ₹19.70 Cr.
It upholds a compliant status. Employing 262 professional, Its leadership includes Vipulkumar Rameshchandra Bhagat (Director), Karan Vipul Bhagat (Director), Forum Vipulkumar Bhagat (Director). It holds ₹30.00 Cr open charges and ₹52.63 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shankar Smruti, Sir Bhalchandra Road Dadar, Mumbai, Maharashtra, 400014.
U33110MH2013PTC245027
245027
29 June 2013
₹19.70 Cr
₹19.70 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Novo Medi Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vipulkumar Rameshchandra Bhagat | Director | 29 Jun 2013 | Current |
| Karan Vipul Bhagat | Director | 30 Sep 2016 | Current |
| Forum Vipulkumar Bhagat | Director | 15 Sep 2015 | Current |
| Anju Sunil Kaudanya | Director | 29 Jun 2013 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Novo Medi Sciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.57% decrease. The company also saw a slight decrease in profitability, with a 3.36% decrease in profit. The company's net worth moved up by a moderate rise of 2.34%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Novo Medi Sciences had a promoter holding of 95.00% and a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹300,000,000.00
₹526,300,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Nov 2023 | Others | ₹30.00 Cr | Open |
| 17 Sep 2021 | Others | ₹18.25 Cr | Satisfied |
| 17 Sep 2021 | Others | ₹8.40 Cr | Satisfied |
| 17 Sep 2021 | Others | ₹4.80 M | Satisfied |
| 17 Sep 2021 | Others | ₹1.25 Cr | Satisfied |
Explore comprehensive loan charge details -
Novo Medi Sciences has a workforce of 262 employees as of Apr 19, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Novo Medi Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novo Medi Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 30.00 Cr registered on 17 Nov 2023 with Charge ID 100835003 was modified on 08 Apr 2025. was recorded as a recent event.
Novo Medi Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Novo Medi Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
A charge registered on 17 Sep 2021 via Charge ID 100486205 with Others was fully satisfied on 26 Dec 2023. was recorded as a recent event.
Progress on A charge registered on 17 Sep 2021 via Charge ID 100486204 with Others was fully satisfied on 26 Dec 2023. was documented.
Progress on A charge registered on 17 Sep 2021 via Charge ID 100486202 with Others was fully satisfied on 26 Dec 2023. was documented.
The CIN of Novo Medi Sciences Private Limited is U33110MH2013PTC245027.
Novo Medi Sciences Private Limited is headquartered at Shankar Smruti, Sir Bhalchandra Road Dadar, Mumbai, Maharashtra, 400014.
Novo Medi Sciences Private Limited was incorporated on 29 June 2013.
The current directors of Novo Medi Sciences Private Limited are
The primary industry of Novo Medi Sciences Private Limited is Manufacturing.
Novo Medi Sciences Private Limited is unlisted.
The authorized capital of Novo Medi Sciences Private Limited is ₹19.70 Cr, and the paid-up capital is ₹19.70 Cr.
The compliance status of Novo Medi Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX